Synageva BioPharma Corp (NASDAQ:GEVA)

98.69
Delayed Data
As of Mar 27
 +6.02 / +6.50%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-25.3M-42.9M-95.5M-192.6M
 
 
 
 
 
Depreciation999.8K4.3M5.6M6.1M
 
 
 
 
 
Total Other Cash Flow924.7K5.6M14.2M28.2M
 
 
 
 
 
Funds From Operations-23.4M-33.1M-75.7M-158.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-6.8M-2.1M-709.0K-8.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.6M-30.9M-75.0M-150.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-195.4M-426.0M-514.3M
 
 
 
 
Decrease In Investments0.000.00272.0M486.7M
 
 
 
Capital Expenditures-682.9K-4.1M-14.6M-16.8M
 
 
 
 
 
Other Investing - Uses0.000.00-1.9M-216.0K
 
 
 
Other Investing - Sources50.1M0.000.000.00
 
 
Net Cash Flow Investing49.4M-199.5M-173.1M-44.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings12.5M0.000.00--
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale186.2K194.1M286.4M215.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.00173.0K
 
 
Net Cash Flow - Financing12.7M194.1M286.4M215.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.0K-6.0K9.0K-106.0K
 
 
 
 
 
 
Net Change In Cash45.5M-36.3M38.2M20.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account